NCT04824703

Brief Summary

To assess the benefits and drawbacks of high versus low oxygen therapy on mortality and myocardial function in mechanically ventilated patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

April 5, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2023

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2023

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

2.1 years

First QC Date

March 26, 2021

Last Update Submit

April 26, 2024

Conditions

Keywords

Oxygen therapy and Mortality

Outcome Measures

Primary Outcomes (2)

  • Change in Stroke volume in milliliters

    Volume of blood in milliliters that is ejected from heart each second and measured By Echocardiography

    Change from Baseline stroke volume At ICU admission and through study completion An average 6 months

  • Change in ejection fraction of heart in percentage

    percentage of blood that's pumped out of a filled ventricle with each heartbeat And measured by echocardiography

    Change from baseline ejection fraction at icu admission and through study completion An Average 6 months

Secondary Outcomes (10)

  • Acute respiratory distress syndrome

    From icu admission date to icu discharge date an average of 2 weeks

  • Sepsis

    From icu admission date to icu discharge date an average of 2 weeks

  • Stroke

    From icu admission date to icu discharge date an average of 2 weeks

  • Mechanical Ventilator free days

    From icu admission date to icu discharge date an average of 2 weeks

  • Shock

    From icu admission date to icu discharge date an average of 2 weeks

  • +5 more secondary outcomes

Study Arms (2)

Conservative oxygen therapy

ACTIVE COMPARATOR

* Spo2 alarm limit will be set as follow: - upper limit 94% and lower limit 88% * If spo2 \>94% Unless fio2 is 0.21%, decrease fio2 by 0.10% at intervals no longer than 5 minutes till spo2 = 94% * If spo2 within target Decrease fio2 0.05% at intervals no longer than 30 min till fio2 0.21% reached or spo2 = 88 % * If spo2 \< 88 % return to previous spo2 that achieve target spo2. * if an arterial blood gas demonstrate that the PaO2 is \< 60 mmHg FiO2 will increased if clinically appropriate irrespective of the SpO2 reading ( target po2 60-100 mmhg ) * During intubation, airway suction, tracheostomy, bronchoscopy, transportation outside of the ICU for radiological or other investigations or for procedures or operations, other critical situations such as hemodynamic collapse, patients will receive standard (non-study)treatment. * Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view

Drug: Oxygen

Liberal oxygen therapy

PLACEBO COMPARATOR

* Spo2 target \> 95% * No specific measures will be taken to avoid high fio2 or high po2 * Use of upper alarm limit for spo2 will be prohibited * Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view

Drug: Oxygen

Interventions

OxygenDRUG

* Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function * administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1

Conservative oxygen therapyLiberal oxygen therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults aged 18 years or older admitted to ICU and expected to receive mechanical ventilation beyond next calendar day

You may not qualify if:

  • severe acute respiratory distress syndrome at time of admission
  • acute Chronic obstructive airway disease exacerbation
  • pregnancy
  • Carbon monoxide poisoning
  • Guillain Barre syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aswan university hospital

Aswān, Egypt

Location

Related Publications (1)

  • Ghazaly HF, Aly AAA, Tammam AS, Hassan MM, Hammad SS, Mahmoud NM, Hemaida TS. Influence of liberal versus conservative oxygen therapies on the hemodynamic parameters of mechanically ventilated patients with sepsis: a randomized clinical trial. BMC Anesthesiol. 2024 Dec 20;24(1):469. doi: 10.1186/s12871-024-02838-6.

MeSH Terms

Interventions

Oxygen

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

March 26, 2021

First Posted

April 1, 2021

Study Start

April 5, 2021

Primary Completion

May 5, 2023

Study Completion

May 11, 2023

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Locations